IDERA PHARMACEUTICALS, INC. 4
4 · IDERA PHARMACEUTICALS, INC. · Filed Dec 12, 2013
Insider Transaction Report
Form 4
Arbeit Robert D.
VP Clinical Development
Transactions
- Award
Stock Option
2013-12-10+200,000→ 200,000 totalExercise: $2.56Exp: 2023-12-10→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The option vests in equal quarterly installments over four years, with the first installment vesting on March 10, 2014.